Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Esophageal and Reflux Surgery (IERS) is a specialized medical center dedicated to the diagnosis and surgical treatment of disorders affecting the esophagus and gastroesophageal junction. Based in Colorado, the institute is a recognized leader in minimally invasive procedures for Gastroesophageal Reflux Disease (GERD), hiatal hernias, and achalasia. IERS is particularly noted for its high volume and expertise with the LINX Reflux Management System, as well as traditional laparoscopic Nissen fundoplication. The center provides a full spectrum of diagnostic services, including high-resolution manometry and pH-impedance monitoring, to facilitate personalized treatment plans. In addition to primary interventions, the institute serves as a major referral center for complex revisional surgeries for patients who have experienced failed prior anti-reflux operations. Through its commitment to clinical excellence and outcomes research, IERS remains a prominent institution in the field of foregut surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Esophageal and Reflux Surgery.